Comparison of Two Commercial Microimmunofluorescence Kits and an Enzyme Immunoassay Kit for Detection of Serum Immunoglobulin G Antibodies to Chlamydia pneumoniae
- 1 May 2001
- journal article
- research article
- Published by American Society for Microbiology in Clinical and Diagnostic Laboratory Immunology
- Vol. 8 (3) , 588-92
Abstract
We compared the MRL and the Labsystems Chlamydia pneumoniae microimmunofluorescence (MIF) immunoglobulin G (IgG) kits and the Labsystems enzyme immunoassay (EIA) kit in a blinded study of 83 serum samples in which we evaluated titers, cross-reactivity to other species, and reproducibility. There was no statistically significant difference between the MRL and the Labsystems MIF kits in the endpoint titers of IgG antibody to C. pneumoniae . The correlation between the results obtained with these two MIF kits was excellent ( r = 0.95; P = 0.001). The cross-reactivity of the C. pneumoniae -positive sera with C. trachomatis - and C. psittaci -positive sera was assessed for each MIF kit. For C. pneumoniae -positive sera with titers of ≥32, the Labsystems MIF kit exhibited more cross-reactivity to C. psittaci than the MRL kit did. The values obtained with the Labsystems EIA kit represented single dilutions of serum specimens expressed as enzymeimmuno units on a continuous scale. The results obtained with the Labsystems EIA kit correlated moderately well with those obtained with each MIF kit when they were compared for their abilities to detect IgG antibodies to C. pneumoniae (for the MRL MIF kit, r = 0.79 [ P = 0.001]; for the Labsystems MIF kit, r = 0.78 [ P = 0.001]). The results obtained with the commercial MRL and Labsystems MIF kits and the Labsystems EIA kit tested were reproducible; and the kits were standardized, had quality control reagents, and are suitable for detection of C. pneumoniae antibodies in serum and for use in interlaboratory studies. Validation of the use of these kits for clinical diagnosis still needs further evaluation.Keywords
This publication has 12 references indexed in Scilit:
- How useful is the Chlamydia micro-immunofluorescence (MIF) test for the gynaecologist?European Journal of Obstetrics & Gynecology and Reproductive Biology, 1999
- Chlamydia pneumoniae and atherosclerosisHeart, 1999
- The species specificity of the microimmunofluorescence antibody test and comparisons with a time resolved fluoroscopic immunoassay for measuring IgG antibodies against Chlamydia pneumoniae.Journal of Clinical Pathology, 1999
- Serological Study of Responses to Selected Pathogens Causing Respiratory Tract Infection in the Institutionalized ElderlyClinical Infectious Diseases, 1996
- Prevalence of Chlamydia trachomatis, Chlamydia psittaci and Chlamydia pneumoniae antibodies in blood donors and attendees of STD clinicsClinical Microbiology and Infection, 1996
- Evaluation of serological methods in the diagnosis ofChlamydia pneumoniae pneumonia during an epidemic in FinlandEuropean Journal of Clinical Microbiology & Infectious Diseases, 1993
- A Seroepidemiologic Study of Chlamydia pneumoniae in Rhode IslandChest, 1993
- Specificity of the microimmunofluorescence assay for the serodiagnosis of Chlamydia pneumoniae infectionsCanadian Journal of Microbiology, 1992
- ChlamydiaeAnnual Review of Microbiology, 1980
- Immunologic Relationship Between Genital Tric, Lymphogranuloma Venereum, and Related Organisms in a New Microtiter Indirect Immunofluorescence TestAmerican Journal of Ophthalmology, 1970